New England Biolabs

M13K07 Helper Phage

#N0315S · cloning

31
Citing papers
233
Combined citations
Supplier page Find this product

Research areas

Monoclonal and Polyclonal Antibodies Research19SARS-CoV-2 and COVID-19 Research5Advanced biosensing and bioanalysis techniques4Bacteriophages and microbial interactions3CAR-T cell therapy research3Advanced Biosensing Techniques and Applications2HER2/EGFR in Cancer Research2DNA and Nucleic Acid Chemistry2

Papers citing this product

1
Engineering of ultra-small diagnostic nanoprobes through oriented conjugation of single-domain antibodies and quantum dots
Protocol Exchange·2012·40 cit.·DOI
2
Identification of COVID-19 B-cell epitopes with phage-displayed peptide library
Journal of Biomedical Science·2021·28 cit.·DOI
3
GDNF family receptor alpha‐like antagonist antibody alleviates chemotherapy‐induced cachexia in melanoma‐bearing mice
Journal of Cachexia Sarcopenia and Muscle·2023·27 cit.·DOI
4
High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries
Scientific Reports·2017·22 cit.·DOI
5
A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
Journal of Nanobiotechnology·2022·22 cit.·DOI
6
Golden Gate assembly with a bi-directional promoter (GBid): A simple, scalable method for phage display Fab library creation
Scientific Reports·2020·17 cit.·DOI
7
Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
Journal of Pharmaceutical Analysis·2023·11 cit.·DOI
8
Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response
npj Vaccines·2023·10 cit.·DOI
9
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T Cell proliferation and anti-tumor immunity in mice
Nature Communications·2024·10 cit.·DOI
10
Screening and Identification of a Novel Anti–Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity
Molecular Pharmacology·2022·8 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.